Suven Life Sciences

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue2.474.705.588.3011.09
Expenses53.9882.01107.5153.90138.70
EBITDA-50.15-75.99-100.57-43.86-124.97
Operating Profit-51.52-77.31-101.92-45.44-127.13
Profit Before Tax-51.52-77.31-101.92-45.60-127.61
Net Profit-51.52-77.31-101.92-45.60-127.61
Financial Ratios
Operating Profit Margin-2,682%-8,260%-3,579%-2,886%-3,501%
Net Profit Margin-2,755%-8,403%-3,627%-3,000%-3,575%
Earning Per Share (Diluted)-2.36-3.48-4.55-2.02-4.84
Dividends Per Share0.000.000.000.000.00